OATP1A2 and OATP2B1 Are Interacting with Dopamine-Receptor Agonists and Antagonists-Reference-Cited by-同舟云学术

OATP1A2 and OATP2B1 Are Interacting with Dopamine-Receptor Agonists and Antagonists

Published:2020-04-28 Issue:6 Volume:17 Page:1987-1995
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Schäfer Anima M.¹^ORCID,Meyer zu Schwabedissen Henriette E.¹^ORCID,Bien-Möller Sandra²,Hubeny Andrea²,Vogelgesang Silke³,Oswald Stefan²⁴^ORCID,Grube Markus²

Affiliation:

1. Biopharmacy, Department Pharmaceutical Sciences, University of Basel, 4056 Basel, Switzerland

2. Center of Drug Absorption and Transport (C_DAT), Department of Pharmacology and Clinical Pharmacology, University Medicine Greifswald, 17487 Greifswald, Germany

3. Department of Pathology, University Medicine Greifswald, 17487 Greifswald, Germany

4. Institute of Pharmacology and Toxicology, Rostock, University Medical Center, 18057 Rostock, Germany

Funder

Universit?t Basel

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.0c00159

Reference52 articles.

1. Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline